Patents by Inventor Jim P. Boyce

Jim P. Boyce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
    Patent number: 7176310
    Abstract: This invention is directed to compound of the following formula (I): wherein R1, R2, R3 and R4 are as described herein. These compounds and pharmaceutical compositions containing the compounds are useful in treating inflammatory disorders in mammals.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: February 13, 2007
    Assignee: UCB SA
    Inventors: Theodore A. Baughman, Jim P. Boyce, Ihab S. Darwish, J. Jeffry Howbert, Nathan C. Ihle, Randy W. Jackson, Scott C. Jeffrey, Dean Maeda, Kraig M. Yager
  • Pharmaceutical uses and synthesis of diketopiperazines
    Patent number: 6815214
    Abstract: The synthesis of novel diketopiperazines, their use in inhibiting cellular events such as those involving NFK-&agr;, NFK-&bgr; and in the treatment of inflammation events, a combinatorial library of diverse diketopiperazines and process for their synthesis as a library and as individual compounds. In particular novel diketopiperazines are disclosed including their synthesis and use in cellular events such as activation of the transcription factor, nuclear factor, TNF-&agr;, TNF-&bgr; and also apoptosis.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: November 9, 2004
    Assignee: Celltech R & D, Inc.
    Inventors: Jim P. Boyce, J. Jeffry Howbert, John C. Tabone
  • Pharmaceutical uses and synthesis of diketopiperazines
    Publication number: 20020187984
    Abstract: The synthesis of novel diketopiperazines, their use in inhibiting cellular events such as those involving NFK-&agr;, NFK-&bgr; and in the treatment of inflammation events, a combinatorial library of diverse diketopiperazines and process for their synthesis as a library and as individual compounds. In particular novel diketopiperazines are disclosed including their synthesis and use in cellular events such as activation of the transcription factor, nuclear factor, TNF-&agr;, TNF-&bgr; and also apoptosis.
    Type: Application
    Filed: December 28, 2001
    Publication date: December 12, 2002
    Applicant: Celltech R & D, Inc.
    Inventors: Jim P. Boyce, J. Jeffry Howbert, John C. Tabone